Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Early research (Phase 1)Study completedNCT02313272What this trial is testingHypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade GliomasWho this might be right forMalignant Glioma H. Lee Moffitt Cancer Center and Research Institute 32
Testing effectiveness (Phase 2)Study completedNCT01806675What this trial is testing18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyWho this might be right forAdult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more Sanjiv Sam Gambhir 25
Early research (Phase 1)WithdrawnNCT00458744What this trial is testingTalotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to TreatmentWho this might be right forBrain and Central Nervous System TumorsLeukemiaLymphoma+1 more Children's Oncology Group
Testing effectiveness (Phase 2)Looking for participantsNCT06161974What this trial is testingStudy of Olutasidenib and Temozolomide in HGGWho this might be right forHigh Grade GliomaAstrocytomaAstrocytoma, Grade III+16 more Rigel Pharmaceuticals 60
Early research (Phase 1)Ended earlyNCT01989052What this trial is testingPh 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent GliomaWho this might be right forMalignant Glioma (WHO Grade III or IV) Annick Desjardins 9
Large-scale testing (Phase 3)Study completedNCT00068952What this trial is testingStudy of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma MultiformeWho this might be right forGlioblastoma Pfizer 118
Testing effectiveness (Phase 2)Ended earlyNCT01011231What this trial is testingStudy of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent GliomaWho this might be right forGlioblastoma University of California, San Francisco 1
Early research (Phase 1)Not Yet RecruitingNCT07455045What this trial is testingA Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG)Who this might be right forHigh Grade Glioma (III or IV)Diffuse Midline Glioma (DMG)Glioblastoma (GBM) Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 40
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Looking for participantsNCT06964737What this trial is testingAnti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV GliomasWho this might be right forRecurrent Malignant GliomaRecurrent WHO Grade 3 GliomaRecurrent WHO Grade 4 Glioma+3 more Ohio State University Comprehensive Cancer Center 30
Not applicableLooking for participantsNCT07675070What this trial is testingSafety and Effectiveness Evaluation of Temozolomide (Amitzo, NanoAlvand) in Patients With Grade III and IV Glioma TumorsWho this might be right forBrain TumorGrade III GliomaGrade IV Glioma NanoAlvand 100
Large-scale testing (Phase 3)Study completedNCT00716976What this trial is testingSodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other MalignancyWho this might be right forBrain TumorCentral Nervous System TumorChildhood Germ Cell Tumor+6 more Children's Oncology Group 131
Early research (Phase 1)Study completedNCT02829931What this trial is testingHypofractionated Stereotactic Irradiation With Nivolumab, Ipilimumab and Bevacizumab in Patients With Recurrent High Grade GliomasWho this might be right forMalignant Glioma H. Lee Moffitt Cancer Center and Research Institute 33
Testing effectiveness (Phase 2)Study completedNCT00005952What this trial is testingTemozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorHead and Neck Cancer+5 more Duke University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06703255What this trial is testingHX301 in Patients with High-grade GilomaWho this might be right forGlioma Hangzhou Hanx Biopharmaceuticals, Ltd. 72
Early research (Phase 1)Active Not RecruitingNCT02142803What this trial is testingTORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid TumorsWho this might be right forAdult GlioblastomaEndometrial Clear Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+21 more National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT01638533What this trial is testingRomidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionWho this might be right forGliomaHematopoietic and Lymphoid Cell NeoplasmLymphoma+47 more National Cancer Institute (NCI) 37
Early research (Phase 1)Study completedNCT00069940What this trial is testingVaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain TumorWho this might be right forBrain and Central Nervous System TumorsGastrointestinal Stromal TumorSarcoma Dana-Farber Cancer Institute
Early research (Phase 1)Study completedNCT00019019What this trial is testingCarboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory LymphomasWho this might be right forBrain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more National Institutes of Health Clinical Center (CC) 70